FREEDBERG JARED (General Counsel and Secretary) received a stock award from INTERCEPT PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/31/2023ACC: 0001104659-23-008585
Officer· General Counsel and Secretary
Since Feb 2021
+32.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
32.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.20K
Price / share
—
Trade value
—
% of position
25.7%
1/27/2023
47.47K→59.67K
Total
Net shares
+12.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2023 | A · Award | +12.20K | — | — | 25.7% | 47.47K | 59.67K |
| Total | +12.20K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
20K shares
Shares
+20K
Strike price
18.40
Held after
20K
Exercisable
—
1/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 1/27/2023 | A · Award | +20K | 18.40 | — | 20K |